<?xml version="1.0" encoding="utf-8"?>
<Document>
  <Do_id>12174137</Do_id>
  <Journal>The British journal of dermatology</Journal>
  <Doc_title>Improvement of psoriasis during imatinib therapy in a patient with a metastatic gastrointestinal stromal tumour.</Doc_title>
  <Doc_abstract>None</Doc_abstract>
  <Doc_ChemicalList>Benzamides;Enzyme Inhibitors;Piperazines;Pyrimidines;Imatinib Mesylate;Protein-Tyrosine Kinases</Doc_ChemicalList>
  <Doc_meshdescriptors>Benzamides;Colonic Neoplasms;Enzyme Inhibitors;Gastrointestinal Neoplasms;Humans;Imatinib Mesylate;Male;Middle Aged;Omentum;Peritoneal Neoplasms;Piperazines;Protein-Tyrosine Kinases;Psoriasis;Pyrimidines;Splenic Neoplasms</Doc_meshdescriptors>
  <Doc_meshqualifiers>therapy;therapeutic use;drug therapy;secondary;therapeutic use;antagonists &amp; inhibitors;drug therapy;therapeutic use;secondary</Doc_meshqualifiers>
</Document>
